Investor FAQs

Investor FAQs

Show All
Where is TFF Pharmaceuticals’ corporate headquarters?
TFF Pharmaceuticals’ corporate headquarters are located in Austin, TX.
Where is the company incorporated?
TFF Pharmaceuticals is incorporated in the state of Delaware.
What is TFF Pharmaceuticals’ fiscal year?
TFF Pharmaceuticals operates on a fiscal year with a year-end of December 31.
How is TFF Pharmaceuticals’ stock traded?
TFF Pharmaceuticals is traded on the NASDAQ stock exchange under the symbol “TFFP”.
Who is TFF Pharmaceuticals’ transfer agent?
TFF Pharmaceuticals’ transfer agent is Philadelphia Stock Transfer (PST). For more information, visit their website: https://carta.com/pst/
How do I report a change to the address on my shareholder account?
You must send both your old and new addresses to our transfer agent, Philadelphia Stock Transfer (PST). Contact Bob Winterle at (484) 416-3124 or bwinterle@philadelphiastocktransfer.com. Each stakeholder in question must sign the request for an address change.
How can I replace a lost stock certificate?
Please contact Bob Winterle at Philadelphia Stock Transfer (PST) at (484) 416-3124 or bwinterle@philadelphiastocktransfer.com. The company can look up your records and make any needed adjustments. Generally, there is a fee involved for replacing lost certificates.
Does TFF Pharmaceuticals have a direct stock purchase plan?
TFF Pharmaceuticals does not offer a direct stock purchase plan.
Who is TFF Pharmaceuticals’ auditor?
Marcum LLP
Who is TFF Pharmaceuticals’ legal counsel?
Greenberg Traurig LLP
Where can I get the latest corporate news releases?
You can view our latest press releases by visiting “News & Events” under the “Investors” section of our website. If you would like to receive email alerts regarding our press releases, please visit our email alerts page.
How can I view documents TFF Pharmaceuticals has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
TFF Pharmaceuticals’ SEC filings can be accessed under “Financial Information” in the “Investors” section of our corporate website or https://www.sec.gov
Whom should I contact regarding investor inquiries?
All investor inquiries should be emailed to our Chief Financial Officer, Kirk Coleman, kcoleman@tffpharma.com.
Top